FDCDDQ
RIGL icon

Federation des caisses Desjardins du Quebec’s Rigel Pharmaceuticals RIGL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$17.5K – 2514
2020
Q4 		$17.5K Buy
+500
New +$14.5K ﹤0.01% 1773
2020
Q1 		– Sell
-1,462
Closed -$31.2K – 2337
2019
Q4 		$31.2K Buy
+1,462
New +$30.1K ﹤0.01% 1631

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RIGL Position: Q1 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Rigel Pharmaceuticals (RIGL) in Q1 2021, closing a stake of 500 shares — an estimated $17.5K sold.

Federation des caisses Desjardins du Quebec first reported a position in RIGL in Q4 2019 and held it in 2 quarters. The position peaked at $31.2K in Q4 2019. 152 funds tracked by Wall St. Rank hold RIGL as of Q1 2021.

  • Federation des caisses Desjardins du Quebec reported no remaining Rigel Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 500 Rigel Pharmaceuticals shares in Q1 2021, an estimated $17.5K.
  • Federation des caisses Desjardins du Quebec first reported a position in Rigel Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Rigel Pharmaceuticals position peaked at $31.2K in Q4 2019.
  • 152 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2021, filed 30 Aug 2024.